Completed NA INTERVENTIONAL 2-arm
NCT07172269
Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes
Evaluation the Effect of Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Type 2 Diabetic Iraqi Patients
Sponsor: Mais Qais Hbeeb
Conditions
Diabete Mellitus Dyslipidemia in Patients With Diabetes Mellitus Insulin Resistance Obesity Type 2 Diabetes Mellitus Type 2 Diabetes
Interventions
Lifestyle Management Sitagliptin + Metformin mangosteen supplement
Updated 1 time since 2025 Last updated: Sep 11, 2025 Started: Sep 15, 2024 Primary completion: May 26, 2025 Completion: May 26, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Diabete Mellitus and Dyslipidemia in Patients With Diabetes Mellitus, this trial is completed. The trial is conducted by Mais Qais Hbeeb and has accumulated 1 data snapshot since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Completed — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Mais Qais Hbeeb
Data source: Al-Mustansiriyah University
For direct contact, visit the study record on ClinicalTrials.gov .